These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8253459)

  • 1. Differentiating malignant pleural mesothelioma from pulmonary adenocarcinoma.
    Gil J
    Hum Pathol; 1993 Sep; 24(9):1036. PubMed ID: 8253459
    [No Abstract]   [Full Text] [Related]  

  • 2. Synchronous occurrence of pulmonary adenocarcinoma and pleural diffuse malignant mesothelioma.
    Imenpour H; Ivaldi GP; Brianti A; Pastorino G; Biggi S; Auriati L; Simonassi C
    Pathologica; 2013 Dec; 105(6):353-6. PubMed ID: 24730341
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mucin-positive epithelial mesothelioma and pseudomesotheliomatous adenocarcinoma.
    Friedman HD; Litovsky SH; Abraham JL
    Arch Pathol Lab Med; 1993 Oct; 117(10):967. PubMed ID: 8215835
    [No Abstract]   [Full Text] [Related]  

  • 4. Pleural mesothelioma in situ and its adenocarcinoma simulator.
    Bono F
    Int J Surg Pathol; 2010 Dec; 18(6):519-20. PubMed ID: 21081535
    [No Abstract]   [Full Text] [Related]  

  • 5. On the diagnosis of malignant pleural mesothelioma: A necropsy-based study of 171 cases (1997-2016).
    Pira E; Boffetta P; Ciocan C
    Tumori; 2019 Aug; 105(4):359-360. PubMed ID: 31418338
    [No Abstract]   [Full Text] [Related]  

  • 6. On the diagnosis of malignant pleural mesothelioma: a necropsy-based study of 171 cases (1997-2016).
    Barbieri PG
    Tumori; 2019 Aug; 105(4):361-362. PubMed ID: 30592233
    [No Abstract]   [Full Text] [Related]  

  • 7. Local recurrence of lung adenocarcinoma 10 years after left upper lobectomy resembling pseudomesotheliomatous adenocarcinoma: a case report.
    Okamoto J; Kubokura H; Motoda N; Hoshina H; Ishii H; Kitayama Y; Usuda J
    J Nippon Med Sch; 2014; 81(3):173-8. PubMed ID: 24998965
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The value of ThinPrep and cytospin preparation in pleural effusion cytological diagnosis of mesothelioma and adenocarcinoma.
    Ylagan LR; Zhai J
    Diagn Cytopathol; 2005 Mar; 32(3):137-44. PubMed ID: 15690333
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Coalescent pleural malignant mesothelioma and adenocarcinoma of the lung, involving only minor asbestos exposure.
    Tsuzuki T; Ninomiya H; Natori Y; Ishikawa Y
    Pathol Int; 2008 Jul; 58(7):451-5. PubMed ID: 18577116
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple-marker immunohistochemical phenotypes distinguishing malignant pleural mesothelioma from pulmonary adenocarcinoma.
    Brown RW; Clark GM; Tandon AK; Allred DC
    Hum Pathol; 1993 Apr; 24(4):347-54. PubMed ID: 7684019
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Coexistent atypical adenomatous hyperplasia, primary lung adenocarcinoma and pleural mesothelioma in an asbestos-exposed subject.
    Thomas DH; Attanoos RL; Gibbs AR
    Histopathology; 2004 Nov; 45(5):540-2. PubMed ID: 15500660
    [No Abstract]   [Full Text] [Related]  

  • 12. Adenocarcinoma simulating mesothelioma.
    Corrin B; Dewar A
    Ultrastruct Pathol; 1996; 20(4):327-9. PubMed ID: 8837338
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pulmonary adenocarcinoma simulating malignant mesothelioma.
    Tang P; Vatsia SK; Teichberg S; Kahn E
    Arch Pathol Lab Med; 2001 Dec; 125(12):1598-600. PubMed ID: 11735699
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pleuropulmonary tumors. Presentation of 2 cases with peculiar clinicopathologic traits].
    Esquius Soriguera J; Alejo Sánchez M; Padilla Navas I; Rodríguez Casquero C; León González C
    Rev Clin Esp; 1989 Oct; 185(6):303-5. PubMed ID: 2623239
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basal lamina reduplication in malignant epithelioid pleural mesothelioma.
    Di Muzio M; Spoletini L; Strizzi L; Procopio A; Tassi G; Casalini A; Modesti A
    Ultrastruct Pathol; 1998; 22(6):467-75. PubMed ID: 9891926
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Early and differential cytologic diagnosis in lung cancer].
    Niţu M; Măceşanu VA; Niţu M; Mărăşescu G
    Pneumologia; 2003; 52(2):126-8. PubMed ID: 14702717
    [No Abstract]   [Full Text] [Related]  

  • 17. Lepidic intrapulmonary growth of malignant mesothelioma presenting as recurrent hydropneumothorax.
    Wu H; Tino G; Gannon FH; Kaiser LR; Pietra GG
    Hum Pathol; 1996 Sep; 27(9):989-92. PubMed ID: 8816899
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glycosaminoglycans in malignant diffuse mesothelioma.
    Kawai T; Suzuki M; Shinmei M; Maenaka Y; Kageyama K
    Cancer; 1985 Aug; 56(3):567-74. PubMed ID: 4005813
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of membranous staining of mesothelioma.
    King JA; Tucker JA
    Cell Vis; 1998; 5(1):24-7. PubMed ID: 9660721
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Malignant mesothelioma.
    Pantanowitz L; Otis CN
    N Engl J Med; 2006 Jan; 354(3):305-7; author reply 305-7. PubMed ID: 16421378
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.